Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

3rd ALS Drug Development Summit 2024

Evvnt Promotion / evvnt
-
21.05.2024 - 23.05.2024  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Temi della conferenza
Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals

Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2215799-3?pid=4832

Speakers: Diego Cadavid Chief Medical Officer Verge Genomics, Disha Sood Senior Scientist Sanofi , Emily Caporello Director, Small Business Program NINDS/NIH , and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2215799-2?pid=4832
Ms. Erin Thomas
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Industry Pricing - Conference + Workshop Day: USD 3597.00, Industry Pricing - Conference Only: USD 2599.00, Service Provider Pricing - Conference + Workshop Day: USD 5197.00, Service Provider Pricing - Conference Only: USD 3699.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Hilfswerk AustriaEuropean Health Forum GasteinCenter of ExcellenceSwiss Tropical and Public Health InstituteAMREF - African Medical and Research FoundationCharité International AcademyHelix - Forschung & Beratung WienAnästhesie in Entwicklungsländern e. V.